These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9398145)

  • 1. Determinants of lipid profile in renal transplant recipients.
    Fabbian F; Squerzanti R; Lambertini D; Gilli P
    Am J Kidney Dis; 1997 Dec; 30(6):934-5. PubMed ID: 9398145
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors influencing plasma lipid profiles including lipoprotein (a) concentrations in renal transplant recipients.
    Wheeler DC; Morgan R; Thomas DM; Seed M; Rees A; Moore RH
    Transpl Int; 1996; 9(3):221-6. PubMed ID: 8723190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid peroxidation in renal allograft recipients.
    Juskowa J; Paczek L; Barańska E; Rancewicz Z; Stryjecka-Rowińska D; Gradowska L; Wyzgał J; Senatorski G; Cieplak M
    Transplant Proc; 1996 Dec; 28(6):3474-6. PubMed ID: 8962351
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperlipidemia in stable renal transplant recipients.
    Ong-Ajyooth L; Sirisalee K; Shayakul C; Vareesangthip K; Vasuvattakul S; Chirawong P; Vanichakarn S; Nimmannit S; Ong-Ajyooth S; Nilwarangkur S
    Transplant Proc; 1994 Aug; 26(4):2062-4. PubMed ID: 8066670
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal lipid and lipoprotein profiles following renal transplantation.
    Moore R; Thomas D; Morgan E; Wheeler D; Griffin P; Salaman J; Rees A
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1060-1. PubMed ID: 8442042
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of obesity on lipid profiles in middle-aged women.
    Maksvytis A; Stakisaitis D
    Medicina (Kaunas); 2004; 40(6):553-7. PubMed ID: 15208478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carotid atherosclerosis in renal transplant recipients: relationships with cardiovascular risk factors and plasma lipoproteins.
    Barbagallo CM; Pinto A; Gallo S; Parrinello G; Caputo F; Sparacino V; Cefalù AB; Novo S; Licata G; Notarbartolo A; Averna MR
    Transplantation; 1999 Feb; 67(3):366-71. PubMed ID: 10030280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microplate methods for determination of serum cholesterol, high density lipoprotein cholesterol, triglyceride and apolipoproteins.
    Shireman RB; Durieux J
    Lipids; 1993 Feb; 28(2):151-5. PubMed ID: 8441340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of immunoassays for the quantitation of plasma Apo B protein.
    Rosseneu M; Vinaimont N; Vercaemst R; Dekeersgieter W; Belpaire F
    Anal Biochem; 1981 Sep; 116(1):204-10. PubMed ID: 7304980
    [No Abstract]   [Full Text] [Related]  

  • 10. The apolipoprotein B/apolipoprotein A-I ratio in healthy men with normolipidemia: limits of variation and relationship with other lipid parameters.
    Kaneva AM; Potolitsyna NN; Bojko ER
    Clin Chem Lab Med; 2014 Dec; 52(12):e291-3. PubMed ID: 24940716
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of LDL-cholesterol results calculated by using apolipoproteins A1, B or HDL-cholesterol for classification of non-chylomicron dyslipidemias].
    Szmidt-Adjid V; Campier A; Pileire B
    Ann Biol Clin (Paris); 1999 May; 57(3):345-50. PubMed ID: 10377488
    [No Abstract]   [Full Text] [Related]  

  • 12. Apolipoprotein CIII is upregulated by anticalcineurins and rapamycin: implications in transplantation-induced dyslipidemia.
    Tur MD; Garrigue V; Vela C; Dupuy AM; Descomps B; Cristol JP; Mourad G
    Transplant Proc; 2000 Dec; 32(8):2783-4. PubMed ID: 11134804
    [No Abstract]   [Full Text] [Related]  

  • 13. Early steroid withdrawal after kidney transplantation.
    Yagisawa T; Toma H; Ota K; Tanabe K; Ishikawa N; Tokumoto N; Yaguchi H; Nakada T
    Transplant Proc; 1996 Jun; 28(3):1342-5. PubMed ID: 8658686
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipid profile in the acute phase of coronary artery disease.
    Batalla A; Reguero JR
    Int J Cardiol; 2001; 80(2-3):265. PubMed ID: 11676391
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxidative stress in renal transplant recipients with chronic rejection: rationale for antioxidant supplementation.
    Vela C; Cristol JP; Maggi MF; Ribstein J; Mimran A; Descomps B; Mourad G
    Transplant Proc; 1999; 31(1-2):1310-1. PubMed ID: 10083585
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperlipidemia in stable renal transplant recipients.
    Divakar D; Bailey RR; Frampton CM; George PM; Walmsley TA; Murphy J
    Nephron; 1991; 59(3):423-8. PubMed ID: 1758532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of treatment with low-dose fluvastatin in hypercholesterolemic renal transplant recipients.
    Akiyama T; Ishii T; Imanishi M; Nishioka T; Matsuura T; Kurita T
    Transplant Proc; 2001 May; 33(3):2115-8. PubMed ID: 11377469
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of human apolipoproteins A-I, B, and E by laser nephelometry.
    Weisweiler P; Schwandt P
    J Clin Chem Clin Biochem; 1984 Jan; 22(1):113-8. PubMed ID: 6421988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDL and clinical and biochemical correlates in Italian non-smoker women.
    Bigazzi F; Pino BD; Forastiere F; Pistelli R; Rossi G; Simoni M; Baldacci S; Viegi G; Bionda A; Sampietro T
    Clin Chem Lab Med; 2004; 42(12):1408-16. PubMed ID: 15576304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenal C19 steroids and serum lipoprotein levels in healthy men.
    Vatalas IA; Dionyssiou-Asteriou A
    Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):388-93. PubMed ID: 12055703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.